Keryx Biopharmaceuticals Announces First Quarter 2013 Financial Results

Published: May 08, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 6, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Wednesday, May 8, 2013 at 8:30 a.m. EDT to discuss results for the first quarter ended March 31, 2013 and a business outlook for the remainder of 2013. Ron Bentsur, Chief Executive Officer of Keryx, will host the call.

Help employers find you! Check out all the jobs and post your resume.

Back to news